Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05918952 · ClinicalTrials.gov registry record
RADx-UP CDCC Rapid Research Pilot Program "Culturally-relevant Community Connections (C3) to Increase COVID-19 Testing
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 327
- Enrollment target
NCT05918952: Completed study, sponsored by Duke University.
NCT05918952 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 327 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05918952 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 327 participants
- Enrollment target
Study Summary
The purpose of this study is to identify barriers and facilitators to COVID testing among members of the Black/African American community. The expected outcome of this project is to increase COVID testing among Black/African American community. The secondary aim is to examine the use of culturally relevant edutainment video messaging combined with trusted opinion leaders in the community as a strategy to increase COVID testing.
Interventions
- DIAGNOSTIC_TEST Covid-19 Antibody Test
- OTHER Short Clip videos
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 327 participants |
| Start Date | 2023-08-21 |
| Est. Completion | 2024-06-13 |
What the finished NCT05918952 record still lists
NCT05918952 is an observational study that tracks outcomes without assigning an intervention. The registered 327 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which Covid-19 Antibody Test is the first listed.
NCT05918952 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05918952 about?
NCT05918952 is a clinical study titled "RADx-UP CDCC Rapid Research Pilot Program "Culturally-relevant Community Connections (C3) to Increase COVID-19 Testing". The purpose of this study is to identify barriers and facilitators to COVID testing among members of the Black/African American community. The expected outcome of this project is to increase COVID testing among Black/African American community. The secondary aim is to examine the use of culturally r...
What is the current status of trial NCT05918952?
This trial is currently completed. The enrollment target is 327 participants. The study started on 2023-08-21. Estimated completion is 2024-06-13.
What interventions are being tested in trial NCT05918952?
The interventions under investigation include: Covid-19 Antibody Test (DIAGNOSTIC_TEST), Short Clip videos (OTHER).
Who is sponsoring clinical trial NCT05918952?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04486378 · 327 participants · Phase 2
A Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients With ctDNA-positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer
- NCT06370182 · 327 participants · NA
Safety and Effectiveness of Mechanical Thrombectomy Using the Anaconda ANA Funnel Catheter
- NCT05156983 · 328 participants · Phase 3
A Study of TAK-330 to Reverse the Effects of Factor Xa Inhibitors For Adults Needing Urgent Surgery
- NCT05380401 · 328 participants · NA
Metabolic Mechanisms Induced by Enteral DHA and ARA Supplementation in Preterm Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI